Home Cart Sign in  
Chemical Structure| 1575591-66-0 Chemical Structure| 1575591-66-0

Structure of Rilzabrutinib
CAS No.: 1575591-66-0

Chemical Structure| 1575591-66-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Rilzabrutinib is a BTK inhibitor.

Synonyms: Rilzabrutinib

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Rilzabrutinib

CAS No. :1575591-66-0
Formula : C36H40FN9O3
M.W : 665.76
SMILES Code : NC1=C2C(=NN(C2=NC=N1)[C@H]3CN(C(C(=CC(C)(C)N4CCN(CC4)C5COC5)C#N)=O)CCC3)C6=C(F)C=C(OC7=CC=CC=C7)C=C6
Synonyms :
Rilzabrutinib
InChI Key :LCFFREMLXLZNHE-GBOLQPHISA-N
Pubchem ID :73388818

Safety of Rilzabrutinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Related Pathways of Rilzabrutinib

RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT06444191 Healthy Volunteers PHASE1 COMPLETED 2021-04-12 Investigational Site Number: 0... More >>001, Glendale, California, 91206, United States Less <<
NCT03395210 Immune Thrombocytopenia|Immune... More >> Thrombocytopenic Purpura Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-12-31 Bleeding and Clotting Disorder... More >>s Institute Site Number : 1087, Peoria, Illinois, 61614, United States|RCCA MC LLC Site Number : 1091, Bethesda, Maryland, 20817-1915, United States|Massachusetts General Hospital Cancer Center Site Number : 1092, Boston, Massachusetts, 02114-2603, United States|Beth Israel Deaconess Medical Center Site Number : 1099, Boston, Massachusetts, 02215, United States|Mid Michigan Medical Center Site Number : 1086, Midland, Michigan, 48670, United States|New York Presbyterian Hospital/Weill Cornell Medical Center Site Number : 1097, New York, New York, 10021, United States|Pitt County Memorial Hospital Site Number : 1095, Greenville, North Carolina, 27834, United States|Seattle Cancer Care Alliance Site Number : 1098, Seattle, Washington, 98109-4405, United States|Investigational Site Number : 105, Canberra, Australian Capital Territory, 2605, Australia|Investigational Site Number : 104, Sydney, New South Wales, 2139, Australia|Investigational Site Number : 102, Woolloongabba, Queensland, 4102, Australia|Investigational Site Number : 101, Clayton, Victoria, 3168, Australia|Investigational Site Number : 106, Parkville, Victoria, 3050, Australia|Investigational Site Number : 103, Perth, Western Australia, 6005, Australia|Investigational Site Number : 213, Pleven, 5800, Bulgaria|Investigational Site Number : 214, Sofia, 1431, Bulgaria|Investigational Site Number : 211, Varna, 9010, Bulgaria|Investigational Site Number : 1161, Toronto, Ontario, M5B 1W8, Canada|Investigational Site Number : 1162, Montreal, Quebec, H3A 1A1, Canada|Investigational Site Number : 431, Brno, 62500, Czechia|Investigational Site Number : 433, Hradec Kralove, 50005, Czechia|Investigational Site Number : 434, Ostrava - Poruba, 70852, Czechia|Investigational Site Number : 432, Praha 2, 12808, Czechia|Investigational Site Number : 727, Rotterdam, 3015 GD, Netherlands|Investigational Site Number : 728, s-Gravenhage, 2545 CH, Netherlands|Investigational Site Number : 542, Bergen, N-5021, Norway|Investigational Site Number : 541, Gralum, 1714, Norway|Investigational Site Number : 981, Leicester, Leicestershire, LE1 5WW, United Kingdom|Investigational Site Number : 983, London, London, City Of, E1 2ES, United Kingdom|Investigational Site Number : 980, London, London, City Of, W12 0HS, United Kingdom|Investigational Site Number : 984, Birmingham, B15 2GW, United Kingdom Less <<
NCT06444204 Hepatic Function Abnormal|Heal... More >>thy Volunteers Less << PHASE1 COMPLETED 2021-03-23 Investigational Site Number: 0... More >>002, Miami, Florida, 33014, United States|Investigational Site Number: 0001, Orlando, Florida, 32809, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.50mL

0.30mL

0.15mL

7.51mL

1.50mL

0.75mL

15.02mL

3.00mL

1.50mL

References

 

Historical Records

Categories